ACCESSIBILITY

24/7

Headlines

06:30

IAI nears $900 million India deal for six aerial refueling aircraft

21:53

Google, Amazon and Intel stumble as investors begin to question the price of the AI boom

12:53

Every student deserves a personal tutor, inside the classroom, too.

09:51

AI companies say their models are the best. Here's how to tell if that's true

Buzz

Most popular

Daily

Weekly

"A gorgeous situation": ServiceNow's CEO celebrates a shrinking workforce

Cyber startup Cyera eyes $20 billion valuation in new funding talks

Stealth Israeli cyber startup valued at over $1.5 billion recruits former 8200 chief

Intel’s $600 million question: How the Kiryat Gat explosion hit its forecast

BrainPOP's mind-blowing deal: Israeli founder nets $875 million from deal with Lego

More news

Pfizer

11 stories about Pfizer

בנימין נתניהו יולי אדלשטיין הגעה של מטוס DHL נתב"ג ישראל משלוח חיסון חיסונים נגד קורונה פייזר

First Pfizer Covid-19 vaccines land in Israel, Netanyahu plans to be first to receive it

09.12.20|Reuters

Israel plans to start administering the doses on Dec. 20, distributor Teva Pharmaceutical Industries said

מארק האפלה מנהל השקעות ראשי בחטיבת ניהול ההון של UBS

Mega-cap tech firms could lag the market next year, but tech in general won't underperform, says UBS chief investment officer

06.12.20|Sophie Shulman

Mark Haefele, Chief Investment Officer at UBS Global Wealth Management, says that stock markets will rise and fall depending on how quickly Covid-19 vaccines are approved and distributed

מנהל המכון הביולוגי נס ציונה פרופ' שמואל שפירא

“Excessive regulation” to blame for delay in Israeli Covid-19 vaccine says professor in charge

30.11.20|CTech

Director of the Israel Institute for Biological Research says vaccines will be distributed in the summer of 2021

New innovative vaccines by Moderna and Pfizer are safe, says top Israeli virologist

24.11.20|Yafit Ovadia

“There isn’t any need for alarm,” says virologist about new coronavirus vaccines

After a coronavirus vaccine is approved, what happens next?

22.11.20|Sophie Shulman

On Dec. 10, the FDA is expected to announce whether it will approve Pfizer’s new vaccine, but 2 trillion people will not receive it until the end of 2021

מימין דרק זנוטו יבגני דיברוב ועידת ניו יורק

Markets may recover from pandemic soon, says CapitalG investor

17.11.20|CTech

Vaccine announcements, possible removal of U.S. travel ban and other factors will contribute to economic recovery, senior investors say in Calcalist and CTech’s Mind the Tech virtual conference

Moderna’s chief scientist says company initiated vaccine deal with Israel

16.11.20|Sophie Shulman

Israeli scientist Tal Zaks says Israel will be among the first to receive doses from the company’s European plant

Pfizer and BioNTech claim 90% effective rate for their Covid-19 vaccine

09.11.20|Reuters

The news comes at the same time that Israel is currently undergoing human trials of its own vaccine for deployment in 2021

As the Covid-19 vaccine arms race intensifies, big money is at risk

10.08.20|Sophie Shulman

Governments want to be among the first to get their hands on the coveted solution, but they are also risking money that could be used to strengthen their healthcare system

Place your bets: Which company will reach a Covid-19 vaccine first?

02.08.20|Sophie Shulman

Moderna may be creating all the buzz, but it is the youngest and least experienced of the contestants, playing an all or nothing game

בריאות דיגיטלית מדעי החיים רפואה טיפול 1

Pfizer Taps Israeli Machine Learning Drug Discovery Company CytoReason

10.01.19|Lilach Baumer

Under the agreement, CytoReason will receive payments "potentially equaling up to low double digit millions" of dollars